BioBridgeXAll companies

Thelium Therapeutics Inc.

Biotechnology company · San Carlos, California, United States

Thelium Therapeutics Inc. is a biotechnology company headquartered in San Carlos, California, United States. Its earliest recorded incorporation is in 2019. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $3.1 million sold in a notice filed in 2022.

www.theliumtx.comProfile compiled from public records. Is this your company? Request a correction or update

Thelium Therapeutics at a glance

Typebiotechnology company
HeadquartersSan Carlos, California, United States
Earliest incorporation on record2019
Employees (self-reported, 2022)5
SEC CIK1926260

What does Thelium Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $1 million in total (2019 to 2022). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $3.1 million sold (2022).

Frequently asked questions about Thelium Therapeutics

Where is Thelium Therapeutics headquartered?

Thelium Therapeutics Inc. is headquartered in San Carlos, California, United States.

What does Thelium Therapeutics do?

Thelium Therapeutics Inc. is a biotechnology company.

When was Thelium Therapeutics founded?

The earliest incorporation on record for Thelium Therapeutics Inc. is in 2019, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences